Research.Patient.info

Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)
This study is testing a new medicine, Onpattro, for a heart condition called ATTR amyloidosis. It compares the medicine to a dummy treatment to see if it improves walking ability and overall heart health in adults.
Denmark · Belgium · Italy